Registered non-profits and charities can now apply for a grant to get free yearly access (valued at $1800) to the powerful Legalese Decoder Business plan. We understand that legal complexities can be ...
deCODE genetics has announced its acquisition of privately-held Icelandic cancer research firm Urdur, Verdandi Skuld (UVS). The acquisition enables deCODE to broaden and enhance its cancer program by ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious ...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback